Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
123.50    1.50 (1.24%)
Bid:
121.00
Ask:
123.50
Spread: 2.50 (2.066%)
Market Cap: £196.76m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Trading update

8 Jun 2018 14:50

RNS Number : 8332Q
Redcentric PLC
08 June 2018
Β 

Redcentric plc

("Redcentric" or the "Company")

Β 

Trading update

Β 

Redcentric plc (AIM: RCN), a leading UK IT managed services provider, is today providing the following update on trading.

Β 

Year ended 31 March 2018 (FY18)

On 19 April 2018, the Board issued a trading update for FY18 reporting that trading results for the year were in line with their expectations and that net debt at 31 March 2018 was Β£27.7m which was better than the Board's expectations.

Β 

The Company expects to report FY18 revenue of Β£100m (of which approximately 87% is recurring), EBITDA of Β£18.1m and reaffirms the previously stated net debt position in its FY18 results which will be announced on 28 June 2018.

Β 

Year ending 31 March 2019 (FY19)

The Board has reviewed the trading outlook for the current financial year and provides the following update.

Β 

Hosting services

In line with a trend experienced across the sector, the Company is seeing the cancellation of some public sector hosting contracts as these customers have decided to move out of Redcentric's data centres into Government-backed facilities. Additionally, there has been some weakness in new business sales in recent months. The Company has already invested in its product functions and sales leadership to drive additional revenues from new and existing services, although the revenue and profit contribution from these initiatives are not expected to make up for the reductions in profit in FY19 from hosting services and recent slower sales. Mitigation of some of these negative effects through cost reductions and other operating efficiencies is possible and actions are already under way.

Β 

Impact of recent public sector contract wins

As previously announced on 26 April 2018, Redcentric was successful in securing the Yorkshire and Humber Public Sector Network contract, one of the largest procurements in the ongoing Health and Social Care Network programme undertaken by the NHS. As is common for these types of contracts, upfront investment and mobilisation costs will be front-end weighted with revenue expected to build significantly over the four year initial term of the contract. There are no changes to the previously announced expectations from this contract which is expected to be strongly positive and profitable over its term, and demonstrates Redcentric's service capabilities and credentials in this market. Redcentric has also been successful in securing one other smaller Health and Social Care Network contract as part of the programme and has a number of bids in various stages of the tender process. If successful, each of these contracts is also likely to have similar short term investment requirements and attractive returns over their lifetime.

Β 

Taken together, the up-front costs of the Yorkshire & Humber Public Sector Network programme, the loss of some public sector hosting business and recent sales softness will impact trading results in FY19.

Β 

Outlook

Because of these factors, the Board has revised its expectations for FY19 downwards with a c.5% reduction in revenue and c.10% reduction in EBITDA against its previous FY19 expectations. This reflects a continuing transition as the business is transforming its operating model to capture the opportunity of customers' adoption of the cloud, and delivering the financial benefits of its Health and Social Care Network contracts. The Board continues to be confident of the medium-term prospects and performance of the Company.

Β 

Β 

Β 

Redcentric plc

Via Tulchan Communications

Chris Jagusz, Chief Executive Officer

Peter Brotherton, Chief Financial Officer

Numis Securities - NOMAD & Joint Broker

+44 (0) 20 7260 1000

Simon Willis / Oliver Hardy / Tom Ballard

finnCap Ltd - Joint BrokerΒ 

+44 (0) 20 7220 0500

Stuart Andrews / Rhys Williams

Tulchan Communications

+44 (0) 207 353 4200

James Macey White / Matt Low

Β 

Β 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
TSTUGUACQUPRGWR
Date   Source Headline
31st May 202411:46 amRNSForm 8.5 (EPT/NON-RI)
31st May 20249:23 amPRNForm 8.3 - Redcentric Plc
30th May 20242:47 pmRNSForm 8.3 - Redcentric PLC
30th May 202410:34 amRNSForm 8.5 (EPT/NON-RI)
30th May 20249:49 amPRNForm 8.3 - Redcentric Plc
29th May 20243:13 pmRNSForm 8.3 - Redcentric PLC
29th May 202411:43 amRNSForm 8.5 (EPT/NON-RI)
29th May 20249:30 amPRNForm 8.3 - Redcentric Plc
29th May 20247:00 amRNSForm 8.3 - Redcentric plc
28th May 20245:17 pmRNSForm 8.3 - Redcentric plc
28th May 20243:57 pmRNSForm 8.3 - Redcentric plc
28th May 20242:47 pmRNSForm 8.3 - Redcentric PLC
28th May 20242:28 pmRNSSI Redstone LLP - Form 8.3 - Redcentric plc
28th May 20241:35 pmEQSForm 8.3 - Apex Fundrock Limited : Re Redcentric plc
28th May 20241:16 pmRNSForm 8.5 (EPT/NON-RI) - Amendment
28th May 202411:49 amRNSForm 8.3 - Redcentric plc
28th May 202411:06 amRNSForm 8.3 - Redcentric PLC
28th May 202410:24 amRNSForm 8.5 (EPT/NON-RI)
28th May 20249:56 amPRNCorrection: Statement regarding Redcentric plc ("Redcentric")
28th May 20249:13 amPRNStatement regarding Redcentric plc ("Redcentric")
24th May 20244:19 pmRNSResponse to press speculation
16th May 20247:00 amRNSTrading Update
14th May 20241:00 pmRNSExercise of Options
19th Apr 20241:30 pmRNSHolding(s) in Company
5th Apr 20247:00 amRNSExercise of Options
20th Mar 202412:30 pmRNSExercise of Options
4th Mar 20244:00 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSDirector/PDMR Shareholding
13th Feb 202412:30 pmRNSDirectorate Change
30th Jan 20244:30 pmRNSDirector/PDMR Shareholding
25th Jan 20244:45 pmRNSDirector/PDMR Shareholding
24th Jan 20246:20 pmRNSExercise of Options
23rd Jan 20244:32 pmRNSDirector/PDMR Shareholding
19th Jan 20247:00 amRNSShare issue in connection with the FY23 Dividend
17th Jan 20245:00 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
11th Jan 20249:45 amRNSDirector/PDMR Shareholding
8th Jan 20244:00 pmRNSDirector/PDMR Shareholding
4th Jan 20241:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20249:00 amRNSDirector/PDMR Shareholding
29th Dec 20237:00 amRNSExercise of Options
27th Dec 20233:30 pmRNSDirector/PDMR Shareholding
20th Dec 202312:00 pmRNSDirector/PDMR Shareholding
18th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20237:00 amRNSExercise of Options
11th Dec 202311:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSDirector/PDMR Shareholding
4th Dec 20237:00 amRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.